Trial intelligence / Profile preview

Hypertonic saline 3% for tramadol toxicity with ECG changes

IRCT20220213054017N1Phase 3Completed

Sponsor
Aja University of Medical Sciences
Start
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of hypertonic saline in tramadol overdose, sponsored by Aja University of Medical Sciences. Primary endpoints: Drug dose, QRS widening and 4 more. Started Sep 2021; status: completed.

02

Drugs

hypertonic saline
03

Conditions

tramadol overdose

Beyond the preview

Go deeper on IRCT20220213054017N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220213054017N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call